| |
| |
|
| Insider
Information: |
Dunlop A. Sinclair |
| Relationship: |
Director |
| City: |
Crestwood |
| State: |
KY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
133,518 |
|
|
Indirect Shares
|
205,853 |
|
|
| Direct
Value |
$5,515,629 |
|
|
|
Indirect Value
|
$8,503,787 |
|
|
| Total
Shares |
339,371 |
|
|
| Total
Value |
$14,019,416 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
14
|
|
Stock
price went up :
|
0
|
7
|
| Stock
price went down : |
0
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 93.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Apellis Pharmaceuticals Inc |
APLS |
Director |
2024-04-12 |
133,518 |
2024-04-12 |
205,853 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
40 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2017-11-13 |
4 |
A |
$0.00 |
$0 |
I/I |
400,679 |
400,679 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2018-05-07 |
4 |
A |
$0.00 |
$0 |
I/I |
94,357 |
280,728 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2019-12-18 |
4 |
S |
$28.55 |
$739,160 |
I/I |
(25,890) |
374,791 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2019-12-19 |
4 |
S |
$28.99 |
$2,483,459 |
I/I |
(85,110) |
249,728 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2019-12-20 |
4 |
S |
$29.53 |
$738,250 |
I/I |
(25,000) |
224,728 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2020-12-04 |
4 |
S |
$50.04 |
$323,455 |
I/I |
(6,436) |
218,292 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2020-12-07 |
4 |
S |
$50.41 |
$941,399 |
I/I |
(18,564) |
199,728 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2020-12-14 |
4 |
S |
$53.86 |
$1,366,713 |
I/I |
(25,000) |
174,728 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2021-04-16 |
4 |
OE |
$14.00 |
$700,000 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2021-04-23 |
4 |
OE |
$14.00 |
$140,000 |
D/D |
10,000 |
60,000 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2021-05-18 |
4 |
S |
$51.66 |
$7,899,847 |
I/I |
(149,488) |
308,291 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2021-05-19 |
4 |
S |
$50.00 |
$380,600 |
I/I |
(7,612) |
300,679 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2021-05-20 |
4 |
S |
$48.10 |
$277,681 |
I/I |
(5,773) |
31,855 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2021-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,108 |
73,108 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2021-06-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(31,855) |
0 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2021-06-01 |
4 |
A |
$0.00 |
$0 |
I/I |
2,682 |
303,361 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2021-09-10 |
4 |
OE |
$14.00 |
$96,516 |
D/D |
6,894 |
66,894 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,230 |
71,124 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-04-22 |
4 |
OE |
$14.00 |
$280,000 |
D/D |
20,000 |
91,124 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2022-06-23 |
4 |
S |
$45.00 |
$675,000 |
I/I |
(15,000) |
285,679 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2022-06-27 |
4 |
S |
$46.79 |
$62,743 |
I/I |
(1,341) |
1,341 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-07-21 |
4 |
OE |
$14.00 |
$134,484 |
D/D |
9,606 |
100,730 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-08-11 |
4 |
S |
$65.63 |
$1,968,900 |
I/I |
(30,000) |
255,679 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-08-16 |
4 |
OE |
$14.00 |
$355,516 |
D/D |
25,394 |
126,124 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-08-25 |
4 |
OE |
$13.19 |
$56,796 |
D/D |
4,306 |
130,430 |
0 |
- |
|
40 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
